Tyra Biosciences Appoints New Chief Medical Officer
Ticker: TYRA · Form: 8-K · Filed: Apr 17, 2026
Sentiment: neutral
Topics: executive-change, personnel
TL;DR
Tyra Biosciences swapped CMOs, bringing in Dr. Jessica Lee to replace Dr. Todd Manetta.
AI Summary
On April 16, 2026, Tyra Biosciences, Inc. filed an 8-K report detailing the departure of Dr. Todd Manetta from his role as Chief Medical Officer. The filing also announced the appointment of Dr. Jessica Lee as the new Chief Medical Officer, effective immediately. Dr. Lee's compensation details were not specified in this particular filing.
Why It Matters
A change in a key executive role like Chief Medical Officer can signal shifts in the company's strategic direction, particularly concerning its drug development pipeline and clinical trial progress.
Risk Assessment
Risk Level: medium — Changes in executive leadership, especially in critical roles like CMO, can introduce uncertainty regarding the company's future strategy and execution.
Key Players & Entities
- Tyra Biosciences, Inc. (company) — Company filing the report
- Dr. Todd Manetta (person) — Departing Chief Medical Officer
- Dr. Jessica Lee (person) — Newly appointed Chief Medical Officer
- 2026-04-16 (date) — Effective date of the reported changes
FAQ
Who has been appointed as the new Chief Medical Officer at Tyra Biosciences?
Dr. Jessica Lee has been appointed as the new Chief Medical Officer.
Who previously held the position of Chief Medical Officer?
Dr. Todd Manetta previously held the position of Chief Medical Officer.
When did these changes in executive officers become effective?
The changes became effective on April 16, 2026.
What is the CIK number for Tyra Biosciences, Inc.?
The CIK number for Tyra Biosciences, Inc. is 0001863127.
What is the primary business of Tyra Biosciences, Inc. according to the filing?
According to the filing, Tyra Biosciences, Inc. is in the Pharmaceutical Preparations industry (SIC 2834).
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on April 17, 2026 by Dr. Todd Manetta regarding Tyra Biosciences, Inc. (TYRA).